Ophthalmology and Vision Science

Ocular Oncology and Eye Tumor Management

Ocular oncology focuses on the diagnosis, treatment, and management of eye tumors, including retinoblastoma, uveal melanoma, conjunctival neoplasms, and orbital tumors. Early detection through advanced imaging modalities such as ultrasound biomicroscopy, optical coherence tomography, fundus photography, and magnetic resonance imaging is essential for optimizing visual outcomes and survival rates. Therapeutic strategies include enucleation, globe-sparing surgeries, radiotherapy, chemotherapy, and targeted molecular therapies. Challenges include balancing tumor eradication with vision preservation, managing rare tumor types, and addressing late presentations in pediatric and adult populations. Artificial intelligence and machine learning tools are increasingly applied for automated tumor detection, grading, and prognosis prediction. Nanotechnology-driven drug delivery and gene therapy approaches are emerging to enhance treatment efficacy while minimizing systemic toxicity. Regulatory authorities ensure that novel oncological drugs, surgical devices, and radiotherapy protocols adhere to international safety and efficacy standards. Current trends focus on precision oncology, minimally invasive interventions, personalized molecular therapies, and collaborative multidisciplinary care involving ophthalmologists, oncologists, and radiation specialists. By combining cutting-edge diagnostics, advanced therapeutics, and rigorous regulatory compliance, ocular oncology continues to improve survival, preserve vision, and enhance patient quality of life while advancing research in eye tumor biology globally.